READ-ONLY DIGITIZATION RESULT
IMpower010: 5-Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB-IIIA Non-Small Cell Lung Cancer.
Cancer Sci · 2026-Mar · PMID 41416818
Panel E提取完成待 EXE 对齐验证
DFS
FIGURE 1 DFS in Japanese patients with stage II–IIIA NSCLC by PD‐L1 status, a stage II–IIIA, or stage IB–IIIA ITT populations. Kaplan–Meier estimates of DFS in the (A) PD‐L1 TC ≥ 1%, (B) PD‐L1 TC 1%–49%, (C) PD‐L1 TC ≥ 50%, (D) stage II–IIIA all‐randomized, and (E) ITT populations are shown. a Evaluated by SP263 assay. BSC, best supportive care; CI, confidence interval; DFS, disease‐free survival; HR, hazard ratio; ITT, intention to treat; NE, not estimable; NSCLC, non‐small cell lung cancer; PD‐L1, programmed death 1 ligand 1; TC, tumor cell.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.1584 | 6.0000 | 12.1905 | 60 | 85 |
| 1 | 2 | 0.0381 | 0.1584 | 8.5121 | 12.1905 | 71 | 85 |
| 1 | 3 | 0.0415 | 0.1584 | 8.7405 | 12.1905 | 72 | 85 |
| 1 | 4 | 0.0450 | 0.1584 | 8.9689 | 12.1905 | 73 | 85 |
| 1 | 5 | 0.0484 | 0.1584 | 9.1972 | 12.1905 | 74 | 85 |
| 1 | 6 | 0.0519 | 0.1584 | 9.4256 | 12.1905 | 75 | 85 |
| 1 | 7 | 0.0554 | 0.1584 | 9.6540 | 12.1905 | 76 | 85 |
| 1 | 8 | 0.0588 | 0.1584 | 9.8824 | 12.1905 | 77 | 85 |
| 1 | 9 | 0.0623 | 0.1584 | 10.1107 | 12.1905 | 78 | 85 |
| 1 | 10 | 0.0657 | 0.1584 | 10.3391 | 12.1905 | 79 | 85 |
| 1 | 11 | 0.0692 | 0.1584 | 10.5675 | 12.1905 | 80 | 85 |
| 1 | 12 | 0.0727 | 0.1584 | 10.7958 | 12.1905 | 81 | 85 |
| 1 | 13 | 0.0761 | 0.1584 | 11.0242 | 12.1905 | 82 | 85 |
| 1 | 14 | 0.0796 | 0.1584 | 11.2526 | 12.1905 | 83 | 85 |
| 1 | 15 | 0.0830 | 0.1584 | 11.4810 | 12.1905 | 84 | 85 |
| 1 | 16 | 0.0865 | 0.1584 | 11.7093 | 12.1905 | 85 | 85 |
| 1 | 17 | 0.0900 | 0.1584 | 11.9377 | 12.1905 | 86 | 85 |
| 1 | 18 | 0.0934 | 0.1584 | 12.1661 | 12.1905 | 87 | 85 |
| 1 | 19 | 0.0969 | 0.1584 | 12.3945 | 12.1905 | 88 | 85 |
| 1 | 20 | 0.1003 | 0.1584 | 12.6228 | 12.1905 | 89 | 85 |
| 1 | 21 | 0.1038 | 0.1584 | 12.8512 | 12.1905 | 90 | 85 |
| 1 | 22 | 0.1073 | 0.1584 | 13.0796 | 12.1905 | 91 | 85 |
| 1 | 23 | 0.1107 | 0.1584 | 13.3080 | 12.1905 | 92 | 85 |
| 1 | 24 | 0.1142 | 0.1584 | 13.5363 | 12.1905 | 93 | 85 |
| 1 | 25 | 0.1176 | 0.1584 | 13.7647 | 12.1905 | 94 | 85 |
| 2 | 1 | 0.0000 | 0.0891 | 6.0000 | 6.8571 | 60 | 92 |
| 2 | 2 | 0.3633 | 0.6832 | 29.9792 | 52.5714 | 165 | 32 |
| 2 | 3 | 0.3668 | 0.6832 | 30.2076 | 52.5714 | 166 | 32 |
| 2 | 4 | 0.3702 | 0.6832 | 30.4360 | 52.5714 | 167 | 32 |
| 2 | 5 | 0.3737 | 0.6832 | 30.6644 | 52.5714 | 168 | 32 |
| 2 | 6 | 0.3772 | 0.6832 | 30.8927 | 52.5714 | 169 | 32 |
| 2 | 7 | 0.3806 | 0.6832 | 31.1211 | 52.5714 | 170 | 32 |
| 2 | 8 | 0.3841 | 0.6832 | 31.3495 | 52.5714 | 171 | 32 |
| 2 | 9 | 0.3875 | 0.6832 | 31.5779 | 52.5714 | 172 | 32 |
| 2 | 10 | 0.3910 | 0.6832 | 31.8062 | 52.5714 | 173 | 32 |
| 2 | 11 | 0.3945 | 0.6832 | 32.0346 | 52.5714 | 174 | 32 |
| 2 | 12 | 0.3979 | 0.6832 | 32.2630 | 52.5714 | 175 | 32 |
| 2 | 13 | 0.4014 | 0.6832 | 32.4913 | 52.5714 | 176 | 32 |
| 2 | 14 | 0.4048 | 0.6832 | 32.7197 | 52.5714 | 177 | 32 |
| 2 | 15 | 0.4083 | 0.6832 | 32.9481 | 52.5714 | 178 | 32 |
| 2 | 16 | 0.4118 | 0.6832 | 33.1765 | 52.5714 | 179 | 32 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-23T17:01:00+00:00 |